Age-dependent sensitivity of cultured peripheral sympathetic neurons to 1-methyl-4-phenylpyridinium: Role of glutathione

Journal of Neurochemistry

Volumn 67, Issue 2, 1996, Pages 557-565

  Bhave, Sanjiv V ^a   Johannessen, Jan N ^b   Lash, Lawrence H ^a   Wakade, Taruna D ^a   Wakade, Arun R ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

1 Methyl 4 phenylpyridinium; Glutathione; L Buthionine S, R sulfoximine; Neuronal cultures; Neurotoxicity; Sympathetic neurons; Tetrabenazine

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; BUTHIONINE SULFOXIMINE; DESIPRAMINE; FREE RADICAL; GLUTATHIONE; GLUTATHIONE SYNTHESIS INHIBITOR; NERVE GROWTH FACTOR; NORADRENALIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHICK EMBRYO; CONCENTRATION RESPONSE; CONTROLLED STUDY; EMBRYO; GLUTATHIONE METABOLISM; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; NORADRENALIN RELEASE; PRIORITY JOURNAL; SYMPATHETIC NERVE; SYNAPSE VESICLE;

ANIMALIA; TRIXIS;

EID: 0030057990     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67020557.x     Document Type: Article

References (59)

1. Adams J. D. Jr., Klaidman L. K., and Odunze I. N. (1989) Oxidative effects of MPTP in the midbrain. Res. Commun. Subst. Abuse 10, 169-180.
2. Barnes N. J. G., Bradbury A. J., Costall B., Domeney A. M., Kelly M. E., and Naylor R. J. (1986) Neuropharmacological manipulations with MPTP. J. Neural Transm. Suppl. 20, 47-63.
3. Bradbury A. J., Costall B., Domeney A. M., Jenner P., Kelly M. E., Marsden C. D., and Naylor R. J. (1986) 1-Methyl-4-phenylpyridine is neurotoxic to the nigrostriatal dopamine pathway. Nature 319, 56-57.
4. Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M., and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 4546-4550.
5. Chiba K., Trevor A., and Castagnoli N. (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-578.
6. +. Free Radic. Biol. Med. 13, 581-583.
7. D'Amato R. J., Alexander G. M., Schwartzman R. J., Kitt C. A., Price D. L., and Snyder S. H. (1987) Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. Nature 327, 324-326.
8. Danias P., Nicklas W. J., Ofori S., Shen J., and Mytilineou C. (1989) Mesencephalic dopamine neurons become less sensitive to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity during development in vitro. J. Neurochem. 53, 1149-1155.
9. + in blood platelets. Clin. Neuropharmacol. 4, 347-349.
10. +) cause rapid ATP depletion in isolated hepatocytes. Biochem. Biophys. Res. Commun. 137, 310-315.
11. Edgar D., Barde Y. A., and Thoenen H. (1981) Subpopulations of cultured chick sympathetic neurons differ in their requirements for survival factors. Nature 289, 294-295.
12. Fariss M. W. and Reed D. J. (1987) High-performance liquid chromatography of thiols and disulfides: dinitrophenyl derivatives. Methods Enzymol. 143, 101-109.
13. +) and not blocked by deprenyl. Life Sci. 39, 1645-1650.
14. Heikkila R. E., Hess A., and Duvoisin R. C. (1984a) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice. Science 224, 1451-1453.
15. Heikkila R. E., Manzino L., Cabbat F. S., and Duvoisin R. C. (1984b) Protection against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by monoamine oxidase inhibitors. Nature 311, 467-469.
16. + within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study. Neuroscience 40, 133-158.
17. Javitch J. A., D'Amato R. J., Strittmatter S. M., and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl. Acad. Sci. USA 82, 2173-2177.
18. Jenner P. (1989) Clues to the mechanism underlying dopamine cell death in Parkinson's disease. J. Neurol. Neurosurg. Psychiatry (Special Suppl.), 22-28.
19. +) within catecholaminergic neurons. Neurotoxicology 12, 285-302.
20. Johannessen J., Chiueh C., Herkenham M., Markey S., Burns R., Adams J., and Schuller H. (1986a) Relationship of the in vivo metabolism of MPTP to toxicity, in MPTP: A Neurotoxin Producing a Parkinsonian Syndrome (Markey S., Castagnoli N., Trever A., and Kopin I., eds), pp. 173-189. Academic Press, Orlando.
21. +) induces oxidative stress in the rodent. Life Sci. 38, 743-749.
22. Johannessen J. N., Chiueh C. C., Bacon J. P., Garrick N. A., Burns R. S., Weise V. K., Kopin I. J., Parisi J. E., and Markey S. P. (1989) Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the dog: effect of pargyline pretreatment. J. Neurochem. 53, 582-589.
23. Kass G. E. N., Wright J. M., Nicotera P., and Orrenius S. (1988) The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium. Arch. Biochem. Biophys. 260, 789-797.
24. Langston J. W., Ballard P., Tetrud J. W., and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979-980.
25. Langston J. W., Forno L. S., Rebert C. S., and Irwin I. (1984) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the squirrel monkey. Brain Res. 292, 390-394.
26. Lash L. H. and Torkarz J. J. (1990) Oxidative stress in isolated rat renal proximal and distal tubular cells. Am. J. Physiol. 259, F338-F347.
27. Lash L. H. and Woods E. B. (1991) Cytotoxicity of alkylating agents in isolated rat kidney proximal and distal tubular cells. Arch. Biochem. Biophys. 286, 46-56.
28. Lash L. H. and Zalups R. K. (1994) Activities of enzymes involved in renal cellular glutathione metabolism after uninephrectomy in the rat. Arch. Biochem. Biophys. 309, 129-138.
29. Liu Y., Roghani A., and Edwards R. H. (1992) Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium. Proc. Natl. Acad. Sci. USA 89, 9074-9078.
30. Lowry O. H., Rosebrough N. J., Farr A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
31. + on sympathetic adrenergic nerves in mouse iris and atrium. Med. Biol. 64, 95-102.
32. Lyden A., Bondesson U., Larsson B. S., Lindquist N. G., and Olsson L. I. (1985) Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues. Acta Pharmacol. Toxicol. (Copenh.) 57, 130-135.
33. Maker H., Weiss C., Silides D. J., and Cohen G. (1981) Coupling of dopamine oxidation (monoamine oxidase activity) to glutathione oxidation via the generation of hydrogen peroxide in rat brain homogenates. J. Neurochem. 47, 1073-1079.
34. Maret G., Testa B., Jenner P., Tayar N. E., and Carrupt P.-A. (1990) The MPTP story: MAO activates tetrahydropyridine derivatives to toxins causing parkinsonism. Drug Metab. Rev. 22, 291-332.
35. Marini A. M., Schwartz J. P., and Kopin I. J. (1989) The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9, 3665-3672.
36. Markey S. P., Johannessen J. N., Chiueh C. C., Burns R. S., and Herkenham M. A. (1984) Intraneuronal generation of a pyridinium metabolite may cause drug induced parkinsonism. Nature 311, 464-467.
37. Mayer R. A., Kindt M. V., and Heikkila R. E. (1986) Prevention of the nigrostriatal toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine by inhibitors of 3,4-dihydroxyphenylethylamine transport. J. Neurochem. 47, 1073-1079.
38. Mytilineou C. and Friedman L. (1988) Studies on the metabolism and toxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultures of embryonic rat mesencephalon. J. Neurochem. 51, 750-755.
39. +) is toxic to mesencephalic dopamine neurons in culture. Neurosci. Lett. 57, 19-24.
40. Naoi M., Takahashi T., and Nagatsu T. (1987) A fluorometric determination of N-methyl-4-phenylpyridinium ion, using high-performance liquid chromatography. Anal. Biochem. 162, 540-545.
41. Nicklas W. J., Vyas I., and Heikkila R. E. (1985) Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenylpyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Life Sci. 36, 2503-2508.
42. Przedborski S., Kostic V., Jackson-Lewis V., Naini A. B., Simonetti S., Fahn S., Carlson E., Epstein C. J., and Cadet J. L. (1992) Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity. J. Neurosci. 12, 1658-1667.
43. 2+ in cultured sympathetic neurons. Neuroscience 52, 973-986.
44. Ramsay R. R., Dadgar J., Treveor A., and Singer T. P. (1986) Energy driven uptake of N-methyl-4-phenylpyridine by brain mitochondria mediates the neurotoxicity of MPTP. Life Sci. 39, 581-588.
45. +. Neurosci. Lett. 75, 323-328.
46. Reinhard J. F. Jr., Diliberto E. J., Viveros O. H., and Daniels A. J. (1987) Subcellular compartmentalization of 1-methyl-4-phenylpyridinium with catecholamines in adrenal medullary chromaffin vesicles may explain the lack of toxicity to adrenal chromaffin cells. Proc. Natl. Acad. Sci. USA 84, 8160-8164.
47. Reinhard J. F. Jr., Diliberto E. J., and Daniels A. J. (1989) Characterization of cellular transport, subcellular distribution, and secretion of the neurotoxicant 1-methyl-4-phenylpyridinium in bovine adrenomedullary cell cultures. J. Neurochem. 52, 1253-1259.
48. +). Naunyn Schmiedebergs Arch. Pharmacol. 346, 158-165.
49. Sanchez-Ramos J. R., Michel P., Weiner W. J., and Hefti F. (1988a) Selective destruction of cultured dopaminergic neurons from fetal rat mesencephalon by 1-methyl-4-phenylpyridinium: cytochemical and morphological evidence. J. Neurochem. 50, 1934-1944.
50. +) increases oxidation of cytochrome-b in rat striatal slices. Brain Res. 443, 183-189.
51. Spina M. B., Squinto S. P., Miller J., Lindsay R. M., and Hyman C. (1992) Brain-derived neurotrophic factor protects dopamine neurons against 6-hydroxydopamine and N-methyl-4-phenylpyridinium ion toxicity: involvement of the glutathione system. J. Neurochem. 59, 99-106.
52. Wakade A. R. and Wakade D. (1982) Relationship between membrane depolarization, calcium influx and norepinephrine release in sympathetic neurons maintained in culture. J. Pharmacol. Exp. Ther. 223, 125-129.
53. 3H] norepinephrine uptake and storage. Brain Res. 359, 397-401.
54. Wakade A. R. and Wakade T. D. (1988) Comparison of transmitter release properties of embryonic sympathetic neurons growing in vivo and in vitro. Neuroscience 27, 1007-1019.
55. Wakade A. R., Edgar D., and Thoenen H. (1982) Substrate requirement and media supplements necessary for the long term survival of chick sympathetic and sensory neurons cultured without serum. Exp. Cell Res. 140, 71-78.
56. Wakade A. R., Prat J. C., and Wakade T. D. (1985) Sympathetic neurons extend neuntes in a culture medium containing cyanide and dinitrophenol but not iodoacetate. FEBS Lett. 190, 95-98.
57. Weiner H. L., Hashim A., Lajtha A., and Sershen H. (1988) (-)-2-Oxo-4-thiazolidine carboxylic acid attenuates 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced neurotoxicity. Res. Commun. Subst. Abuse 9, 53-60.
58. Westlund K. N., Denney R. M., Kochenperger L. M., Rose R. M., and Abell C. W. (1985) Distinct monoamine oxidase A and B populations in primate brain. Science 230, 181-183.
59. Zalups R. K. and Lash L. H. (1990) Effects of uninephrectomy and mercuric chloride on renal glutathione homeostasis. J. Pharmacol. Exp. Ther. 254, 962-970.